REPROCELL advances human health by delivering cutting-edge products and services that shape the future of regenerative medicine.

We specialize in custom GMP-grade Master Cell Banks (MCBs) of iPSCs, iPSC-derived MSCs (iMSCs), and conventional MSCs, manufactured in compliance with FDA, EMA, and PMDA standards. Our Clinical iPSC Seed Clones are generated using proprietary StemRNA™ footprint-free RNA reprogramming, ensuring genetic integrity and clinical readiness.

Sponsors can de-risk development by evaluating fully characterized iPSC Pilot Clones prior to GMP manufacturing or clinical gene editing.

REPROCELL provides an integrated platform spanning human tissue sourcing, footprint-free reprogramming, custom gene editing, GMP manufacturing, cell banking, translational models, and clinical-grade analytics—enabling biotech, pharma, and academic partners to move next-generation cell and gene therapies from concept to clinic.